NCT03153046 The Effects of Prebiotics on Cognitive Functioning and Weight Gain in Psychosis Status COMPLETED Phase NA
NCT03150771 Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia Status COMPLETED Phase PHASE1
NCT03146364 Evaluation of Executive Function With Virtual Reality Among People With Schizophrenia Status UNKNOWN Phase NA
NCT03140475 Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition Status COMPLETED Phase N/A
NCT03132571 Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia Status TERMINATED Phase PHASE2
NCT03131505 INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1 Status COMPLETED Phase N/A
NCT03130478 Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain Status COMPLETED Phase N/A
NCT03130465 Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia Status UNKNOWN Phase N/A
NCT03121586 Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia Status TERMINATED Phase PHASE3
NCT03117452 Evaluation of a Visual Remediation Intervention for Schizophrenia Status UNKNOWN Phase NA
NCT03114488 Modulating Human Cortical Plasticity With Transcranial Electrical Stimulation Status COMPLETED Phase NA
NCT03092687 Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core Status TERMINATED Phase N/A
NCT03090503 Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up Status UNKNOWN Phase PHASE4
NCT03090490 10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals Status UNKNOWN Phase NA
NCT03080194 The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia Status UNKNOWN Phase PHASE4